From the ER to the operating room; pathogen free air is critical. UV Breeze provides the ability to reduce the risk of airborne transmission of SARS-CoV-2, Influenza A, and other pathogens in high risk areas.

Currently engaging the FDA for review and approval, UV Breeze expects to be FDA certified in the near future.